PR NEWSWIRE

Previous Stories

SocietyOne doubles down on broker channel with expanded Loan Market Group partnership

Dec 16 2021 - PR NewsWire

SYDNEY, Dec. 16, 2021 /PRNewswire/ — Digital finance platform SocietyOne has expanded its partnership with Australasia’s largest broker network, Loan…


XPN Technologies Group Ltd (XPN) lists on the ASX following well supported A$12.5m IPO

Dec 16 2021 - PR NewsWire

Australian based marketing technology and cloud business, XPON is set to list on the Australian Securities Exchange (ASX) today from…


Awards and Demand for Process Automation Software Propels Nintex into 2022

Dec 16 2021 - PR NewsWire

Industry recognition for Nintex and its commitment to customer success paves the way for organisations to accelerate digital transformation in…


AUSTRALIAN LIFE SCIENCE COMPANY, QBIOTICS, LAUNCHES STELFONTA® ITS LEAD VETERINARY PHARMACEUTICAL IN AUSTRALIA, FOLLOWING LAUNCHES IN OTHER KEY GLOBAL MARKETS

Dec 16 2021 - PR NewsWire

QBiotics commences the Australian commercial launch of its lead veterinary drug, STELFONTA®, which is approved by the Australian Pesticides and…


FDA Breakthrough Devices Designation Application to Fast-Track Painful Finger-Prick Alternative for People Living with Diabetes

Dec 16 2021 - PR NewsWire

SYDNEY, Dec. 15, 2021 /PRNewswire/ — Life Science Biosensor Diagnostics Pty Ltd (LSBD), a life sciences and medical technology company…


NEW POLL: AUSTRALIAN PUBLIC CALLS FOR COMPOSTABLE PACKAGING, NOT PLASTIC

Dec 15 2021 - PR NewsWire

LONDON, Dec. 15, 2021 /PRNewswire/ — LANDMARK new poll reveals 85 percent of the Australian public believe more food should…


App Annie and AppsFlyer’s State of App Marketing report Explores the Rise of the ‘App Tourist’ in ANZ

Dec 15 2021 - PR NewsWire

SYDNEY, Dec. 15, 2021 /PRNewswire/ – App Annie, the leading mobile data and analytics company, and AppsFlyer, the marketing measurement and…


Alterity Therapeutics Announces First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

Dec 14 2021 - PR NewsWire

Initiation of Phase 2 Clinical Trial Expected in CY Q1 2022 MELBOURNE, Australia, Dec. 14, 2021 /PRNewswire/ — Alterity Therapeutics (ASX:…


CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd

Dec 14 2021 - PR NewsWire

MELBOURNE, Australia and ST. GALLEN, Switzerland, Dec. 14, 2021 /PRNewswire/ — CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd–…


Hyundai Help for Kids hits $10 million fundraising milestone

Dec 14 2021 - PR NewsWire

Hyundai Help for Kids, Hyundai Australia’s charitable arm, has now donated an incredible $10 million to charities around the country…


Analyse The Market From A Different Angle